Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

X-Aptamer Technology Identifies C4A and ApoB in Blood as Potential Markers for Schizophrenia
Consuelo Walss‐Bass, G.L. Lokesh, Elena Dyukova, et al.
Complex Psychiatry (2018) Vol. 5, Iss. 1, pp. 52-59
Open Access | Times Cited: 20

Showing 20 citing articles:

Translation of aptamers toward clinical diagnosis and commercialization
Shan Liu, Yixin Xu, Jiang Xin, et al.
Biosensors and Bioelectronics (2022) Vol. 208, pp. 114168-114168
Closed Access | Times Cited: 54
Dysregulation of complement and coagulation pathways: emerging mechanisms in the development of psychosis
Meike Heurich, Melanie Föcking, David Mongan, et al.
Molecular Psychiatry (2021) Vol. 27, Iss. 1, pp. 127-140
Open Access | Times Cited: 47
The complement system in neurodegenerative diseases
Jacqui Nimmo, Robert A. J. Byrne, Nikoleta Daskoulidou, et al.
Clinical Science (2024) Vol. 138, Iss. 6, pp. 387-412
Open Access | Times Cited: 7
Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies
David Mongan, Sophie Sabherwal, Subash Raj Susai, et al.
Schizophrenia Research (2020) Vol. 222, pp. 58-72
Open Access | Times Cited: 35
Overexpression of complement component C4 in the dorsolateral prefrontal cortex, parietal cortex, superior temporal gyrus and associative striatum of patients with schizophrenia
Romain Rey, Marie‐Françoise Suaud‐Chagny, Anne-Lise Bohec, et al.
Brain Behavior and Immunity (2020) Vol. 90, pp. 216-225
Open Access | Times Cited: 35
The plasma peptides of Alzheimer’s disease
Angelique Florentinus-Mefailoski, Peter Bowden, Philip Scheltens, et al.
Clinical Proteomics (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 29
Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability
Alexandros Hatzimanolis, Stefania Foteli, Pentagiotissa Stefanatou, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 272, Iss. 7, pp. 1219-1228
Open Access | Times Cited: 19
Differential associations between cytokine and complement proteins in the clinical high risk and first episode stages of psychosis: Blood based investigation across three international studies of psychosis: NEURAPRO, STEP and OPTiMiSE
Subash Raj Susai, Rachel Davis, David Mongan, et al.
Research Square (Research Square) (2025)
Closed Access
Diagnostic and Therapeutic Value of Aptamers in Envenomation Cases
Steven Ascoët, Michel De Waard
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3565-3565
Open Access | Times Cited: 24
Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia
João A. Rodrigues, Ana Martinho, Cátia Santa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4917-4917
Open Access | Times Cited: 16
Relationship of selective complement markers with schizophrenia
Abdull Jalil Mohd Asyraf, Abd Rahim Nour El Huda, Mohd Noor Hanisah, et al.
Journal of Neuroimmunology (2021) Vol. 363, pp. 577793-577793
Open Access | Times Cited: 17
A scoping review of protein biomarkers for schizophrenia: state of progress, underlying biology, and methodological considerations
Caio Henrique de Souza Ferreira Berdeville, Danyelle Silva-Amaral, Paulo Dalgalarrondo, et al.
Neuroscience & Biobehavioral Reviews (2024), pp. 105949-105949
Closed Access | Times Cited: 2
Plasma complement component 4 alterations in patients with schizophrenia before and after antipsychotic treatment
Jingfeng Su, Feng Xia, Kaiyuan Chen, et al.
Asian Journal of Psychiatry (2022) Vol. 73, pp. 103110-103110
Closed Access | Times Cited: 8
Association between cognitive impairment and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia
Wen‐Wang Rao, Yunshu Zhang, Keqing Li, et al.
Aging (2021) Vol. 13, Iss. 12, pp. 16353-16366
Open Access | Times Cited: 9
Synthesis and characterization of novel ssDNA X-aptamers targeting Growth Hormone Releasing Hormone (GHRH)
Burcu Ayhan‐Sahin, Zeynep-Elif Apaydın, Pınar Obakan Yerlikaya, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0260144-e0260144
Open Access | Times Cited: 4
Identification of new aptamer BC-3 targeting RPS7 from rapid screening for bladder carcinoma
Yunyi Liu, Juan Li, OU Hai-long, et al.
Genes & Diseases (2022) Vol. 10, Iss. 5, pp. 2137-2150
Open Access | Times Cited: 3
The plasma level of complement component 4A decreases with aripiprazole treatment in patients with early psychosis
Chih‐Min Liu, Chen‐Chung Liu, Ming H. Hsieh, et al.
Psychiatry Research (2022) Vol. 316, pp. 114775-114775
Closed Access | Times Cited: 3
Advancements and Challenges in Aptamer-Based Therapeutics and Diagnostics Across Diverse Medical Domains: A Comprehensive Review
Ahmed S.A. Ali Agha, Walhan Alshaer, Talal Aburjaı
Jordan Journal of Pharmaceutical Sciences (2024) Vol. 17, Iss. 2, pp. 344-361
Closed Access
Association between clinical symptoms and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia
Wen‐Wang Rao, Xiangfei Meng, Keqing Li, et al.
Annals of General Psychiatry (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 2
DNA methylation and copy number variation of the complement C4A gene in schizophrenia
Abdull Jalil Mohd Asyraf, Abd Rahim Nour El Huda, Mohd Noor Hanisah, et al.
Gene Reports (2022) Vol. 29, pp. 101702-101702
Closed Access
Page 1

Scroll to top